Towards Targeting PI3K-Dependent Regulation of Gene Expression in Brain Cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Towards Targeting PI3K-Dependent Regulation of Gene Expression in Brain Cancer
Authors
Keywords
-
Journal
Cancers
Volume 9, Issue 12, Pages 60
Publisher
MDPI AG
Online
2017-05-30
DOI
10.3390/cancers9060060
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis
- (2017) Zhongrun Qian et al. INTERNATIONAL JOURNAL OF CANCER
- FoxO3a induces temozolomide resistance in glioblastoma cells via the regulation of β-catenin nuclear accumulation
- (2017) Ke Xu et al. ONCOLOGY REPORTS
- Allosteric MEK1/2 inhibitors including cobimetanib and trametinib in the treatment of cutaneous melanomas
- (2017) Robert Roskoski PHARMACOLOGICAL RESEARCH
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
- (2016) Michele Ceccarelli et al. CELL
- A small molecule inhibitor of NFκB blocks ER stress and the NLRP3 inflammasome and prevents progression of pancreatitis
- (2016) Mazhar A. Kanak et al. JOURNAL OF GASTROENTEROLOGY
- Role of CREB on heme oxygenase-1 induction in adrenal cells: involvement of the PI3K pathway
- (2016) F Astort et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells
- (2016) B Mitton et al. LEUKEMIA
- PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
- (2016) Xiaoman Li et al. Oncotarget
- Suppression of the invasive potential of Glioblastoma cells by mTOR inhibitors involves modulation of NFκB and PKC-α signaling
- (2016) Goparaju Chandrika et al. Scientific Reports
- Systemic Inhibition of CREB is Well-tolerated in vivo
- (2016) Bingbing X. Li et al. Scientific Reports
- Dimethyl Fumarate Inhibits the Nuclear Factor κB Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein
- (2015) Irida Kastrati et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of a Potent Inhibitor of CREB-Mediated Gene Transcription with Efficacious in Vivo Anticancer Activity
- (2015) Fuchun Xie et al. JOURNAL OF MEDICINAL CHEMISTRY
- Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity
- (2015) Alexandra Van Keymeulen et al. NATURE
- Phase II study of PX-866 in recurrent glioblastoma
- (2015) M. W. Pitz et al. NEURO-ONCOLOGY
- A Novel Small-Molecule Inhibitor Targeting CREB-CBP Complex Possesses Anti-Cancer Effects along with Cell Cycle Regulation, Autophagy Suppression and Endoplasmic Reticulum Stress
- (2015) Jong Woo Lee et al. PLoS One
- The NFκB pathway: a therapeutic target in glioblastoma
- (2015) Lorena Nogueira et al. Oncotarget
- The NFκB inhibitor, SN50, induces differentiation of glioma stem cells and suppresses their oncogenic phenotype
- (2014) Li Zhang et al. CANCER BIOLOGY & THERAPY
- Treatment Considerations for MGMT-Unmethylated Glioblastoma
- (2014) Jennie W. Taylor et al. Current Neurology and Neuroscience Reports
- A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K
- (2014) Daniel J. Ma et al. NEURO-ONCOLOGY
- Evaluation of the Impact of the Cancer Therapy Everolimus on the Central Nervous System in Mice
- (2014) Martine Dubois et al. PLoS One
- The Gene Expression Response of Chronic Lymphocytic Leukemia Cells to IL-4 Is Specific, Depends on ZAP-70 Status and Is Differentially Affected by an NFκB Inhibitor
- (2014) Natalia Ruiz-Lafuente et al. PLoS One
- Selective CREB-dependent cyclin expression mediated by the PI3K and MAPK pathways supports glioma cell proliferation
- (2014) P Daniel et al. Oncogenesis
- Physiological expression of the PI3K-activating mutationPik3caH1047Rcombines withApcloss to promote development of invasive intestinal adenocarcinomas in mice
- (2013) Lauren M. Hare et al. BIOCHEMICAL JOURNAL
- Mutationally Activated PIK3CAH1047R Cooperates with BRAFV600E to Promote Lung Cancer Progression
- (2013) C. L. Trejo et al. CANCER RESEARCH
- Proteasome inhibitor MG132 induces selective apoptosis in glioblastoma cells through inhibition of PI3K/Akt and NFkappaB pathways, mitochondrial dysfunction, and activation of p38-JNK1/2 signaling
- (2012) Alfeu Zanotto-Filho et al. INVESTIGATIONAL NEW DRUGS
- An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice
- (2012) Kathryn M. Kinross et al. JOURNAL OF CLINICAL INVESTIGATION
- PI3K signalling: the path to discovery and understanding
- (2012) Bart Vanhaesebroeck et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Conditional activation of Pik3ca H1047R in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations
- (2012) W Yuan et al. ONCOGENE
- The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB
- (2012) Eric R Kandel Molecular Brain
- CREB Is a Novel Nuclear Target of PTEN Phosphatase
- (2011) T. Gu et al. CANCER RESEARCH
- Antitumor Activity of NVP-BKM120--A Selective Pan Class I PI3 Kinase Inhibitor Showed Differential Forms of Cell Death Based on p53 Status of Glioma Cells
- (2011) D. Koul et al. CLINICAL CANCER RESEARCH
- Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors
- (2011) Johanna C. Bendell et al. JOURNAL OF CLINICAL ONCOLOGY
- NFκB inhibitors induce cell death in glioblastomas
- (2010) Alfeu Zanotto-Filho et al. BIOCHEMICAL PHARMACOLOGY
- NFKBIADeletion in Glioblastomas
- (2010) Markus Bredel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Co-Depletion of Cathepsin B and uPAR Induces G0/G1 Arrest in Glioma via FOXO3a Mediated p27Kip1 Upregulation
- (2010) Sreelatha Gopinath et al. PLoS One
- Differential Response of Glioma Cells to FOXO1-Directed Therapy
- (2009) Cara J. Lau et al. CANCER RESEARCH
- cAMP Response Element Binding Protein Is Required for Mouse Neural Progenitor Cell Survival and Expansion
- (2009) Sebastian Dworkin et al. STEM CELLS
- Cyclic AMP Response Element-Binding Protein Overexpression: A Feature Associated with Negative Prognosis in Never Smokers with Non-Small Cell Lung Cancer
- (2008) H.-S. Seo et al. CANCER RESEARCH
- Growth Suppression of Lung Cancer Cells by Targeting Cyclic AMP Response Element-Binding Protein
- (2008) S. Aggarwal et al. CANCER RESEARCH
- Unravelling the tumor-suppressive functions of FOXO proteins
- (2008) Tobias B. Dansen et al. TRENDS IN CELL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started